BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 8:11:26 AM | Browse: 458 | Download: 875
 |
Received |
|
2020-10-22 14:08 |
|
Peer-Review Started |
|
2020-10-22 14:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-07 19:40 |
|
Revised |
|
2021-01-16 13:14 |
|
Second Decision |
|
2021-02-22 03:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-03-08 06:08 |
|
Articles in Press |
|
2021-03-08 06:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-14 02:03 |
|
Typeset the Manuscript |
|
2021-03-29 12:20 |
|
Publish the Manuscript Online |
|
2021-04-09 08:11 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Case Report |
| Article Title |
Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lin Xiao, Lie Sun, Kang Zhao and Yi-Sheng Pan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yi-Sheng Pan, MD, Doctor, Department of General Surgery, Peking University First Hospital, No. 8 Xishiku Street, Beijing 100034, China. bdyypanyisheng@163.com |
| Key Words |
Crohn's disease; Infliximab; Colon cancer; Rectum cancer; Inflammatory bowel disease; Tumor necrosis factor; Case report |
| Core Tip |
Crohn's disease can result in diffuse intestinal lesions, including intestinal edema, stenosis, and even mucosal bleeding, which makes pathological diagnosis difficult. Although tumor necrosis factor-alpha inhibitors are efficacious for inflammatory bowel disease, they may contribute to malignancy in particularly susceptible individuals. This case demonstrates that when a patient is receiving long-term treatment with infliximab, it is important to monitor for the development of neoplasia. When neoplasia is found, surgical resection must be performed in time to prevent tumor progression and spread. |
| Publish Date |
2021-04-09 08:11 |
| Citation |
Xiao L, Sun L, Zhao K, Pan YS. Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report. World J Gastrointest Oncol 2021; 13(4): 305-311 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i4/305.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i4.305 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
